Clinical Trials in Littleton, United States
Locations / Littleton, United States
Delta Trials catalogs 72 clinical trials conducted in Littleton, United States, making it a notable site of clinical research activity. These trials spanning 530 distinct medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations in Littleton evolve over time.
72
Total Trials
530
Conditions
1
Terminated since 2020
Browse by condition (530 total)
- Stage iiib lung cancer ajcc v8 4 trialsAll Stage iiib lung cancer ajcc v8 trials
- Stage iii lung cancer ajcc v8 3 trialsAll Stage iii lung cancer ajcc v8 trials
- All Clinical stage iii cutaneous melanoma ajcc v8 trials
- Recurrent ovarian carcinoma 3 trialsAll Recurrent ovarian carcinoma trials
- Neuroendocrine tumor g2 3 trialsAll Neuroendocrine tumor g2 trials
- All Recurrent ovarian clear cell adenocarcinoma trials
- Stage ii lung cancer ajcc v8 3 trialsAll Stage ii lung cancer ajcc v8 trials
- Chronic lymphocytic leukemia 3 trialsAll Chronic lymphocytic leukemia trials
- Stage iiia lung cancer ajcc v8 3 trialsAll Stage iiia lung cancer ajcc v8 trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials
- All Recurrent ovarian endometrioid adenocarcinoma trials
- All Recurrent platinum-resistant primary peritoneal carcinoma trials
- All Primary peritoneal high grade serous adenocarcinoma trials
- All Pathologic stage iii cutaneous merkel cell carcinoma ajcc v8 trials
- All Recurrent fallopian tube undifferentiated carcinoma trials
- Vaginal adenocarcinoma 2 trialsAll Vaginal adenocarcinoma trials
- Malignant solid neoplasm 2 trialsAll Malignant solid neoplasm trials
- Anal canal cloacogenic carcinoma 2 trialsAll Anal canal cloacogenic carcinoma trials
- Endometrioid adenocarcinoma 2 trialsAll Endometrioid adenocarcinoma trials
- Neuroendocrine neoplasm 2 trialsAll Neuroendocrine neoplasm trials